acute kidney injury (AKI), often requiring renal replacement therapy (RRT). Serum Cystatin C
(sCysC) and serum Neutrophil Gelatinase-Associated Lipocalin (sNGAL) are emerging
biomarkers for kidney injury, and were suggested to be superior to serum creatinine (sCr) in
several clinical settings. Moreover, elevated sCysC is associated with disease severity and
mortality in COVID-19. We aimed to assess the utility of sCysC and sNGAL for predicting …